Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1185 |
| Name of the vaccine | CTH522 (CHLM-02) |
| Microbe | Bacteria |
| Disease name | Trachoma |
| Name of bacteria | Chlamydia trachomatis |
| Type of vaccine | Recombinant |
| Nucleic acid content | DNA |
| Age | 18 to 45 years |
| Description of the vaccine | Chlamydia vaccine. |
| Name of the manufacturer | Statens Serum Institut |
| Name of the manufacturing country | United Kingdom |
| Year of manufacture | 2022 |
| Clinical Phase status | Clinical - Phase 1 |
| Bacterial strain | Gram-negative bacterium. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Three doses. |
| Mechanism of action | Anti-CTH522 IgG seroconversion. |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | CAF09b, CAF01 |
| Repurposing | For chlamydia. |
| Side effects of vaccine | Mild local injection-site reactions. |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | 31416692 |
| Clinical trial number | NCT03926728 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |